Home-Based Functional Electrical Stimulation for Lower Limb Rehabilitation in Stroke Patients. (FES)
Feasibility and Effectiveness of Home-Based Functional Electrical Stimulation (FES) for Lower Limb Rehabilitation in Post-Stroke Individuals
This assessor-blinded, randomized, parallel-group feasibility trial will evaluate the feasibility and preliminary effectiveness of a home-based Functional Electrical Stimulation (FES) system for lower-limb rehabilitation in adults recovering from stroke. The study will be conducted at two sites within the INSTRUCT Network in India.
Adults aged 18 years or older who are 1 month to 1 year post-stroke and have mild to moderate lower-limb weakness will be eligible to participate. A total of 70 participants will be randomly allocated in a 1:1 ratio to either a home-based FES intervention group or a control group receiving standard rehabilitation.
Participants in the FES group will receive training on safe and independent use of the FES device before commencing home treatment. FES will be delivered to selected lower-limb muscles, including the quadriceps, tibialis anterior, and hamstrings, for 30 minutes per session, 5 sessions per week, for 12 weeks. The intervention will be supported by a smartphone-based telerehabilitation platform that will provide remote clinician support, training, adherence monitoring, and troubleshooting. The FES system is being developed with IoT-enabled monitoring and ECG-based heart-rate safety monitoring to facilitate safe home use.
Participants in the control group will receive standard outpatient care and home-based rehabilitation without FES. Both groups will receive equivalent remote clinician contact and education.
The primary purpose of the study is to determine the feasibility of home-based FES, including recruitment, retention, adherence to prescribed treatment sessions, safety, and participants' ability to independently operate the device at home. Secondary evaluation will assess preliminary changes in functional walking ability using the 6-Minute Walk Test (6MWT), measured at baseline and after 12 weeks.
The study is intended to generate feasibility and preliminary effectiveness data to inform the design of a future, adequately powered randomized controlled trial and to assess the potential for wider implementation of home-based FES rehabilitation for people recovering from stroke.
研究概览
详细说明
Stroke is a major cause of long-term disability and frequently results in impaired lower-limb motor function, reduced walking ability, and limitations in independent mobility. Although functional electrical stimulation (FES) is an established rehabilitation approach for activating peripheral nerves and muscles to facilitate functional movement, conventional FES-based rehabilitation is often delivered in clinical settings and may require repeated supervision, accurate electrode placement, and technical assistance. These requirements can limit access to rehabilitation, particularly for individuals who have difficulty attending frequent outpatient sessions.
This study will investigate the feasibility of delivering FES as a home-based rehabilitation intervention supported by a smartphone-based telerehabilitation platform. The project incorporates development and clinical evaluation of an indigenous FES system designed for home use. The system is being developed with features intended to support safe and independent use, including IoT-enabled monitoring of device use and an ECG-based heart-rate monitoring component. The accompanying smartphone platform is intended to facilitate remote training, clinician follow-up, adherence monitoring, safety monitoring, and troubleshooting.
Condition The study will include adults recovering from stroke, including ischemic and hemorrhagic stroke, with lower-limb motor impairment. The study focuses on post-stroke lower-limb dysfunction and limitations in functional walking ability.
Study Design This is an assessor-blinded, randomized, parallel-group, active-controlled feasibility trial. The study will be conducted at two sites within the INSTRUCT Network in India. Eligible participants will be randomly allocated to either the home-based FES intervention or standard rehabilitation. Outcome assessment will be performed by assessors who are blinded to treatment allocation where feasible.
The project consists of two broad phases. The first phase involves development and validation of the home-based FES system at IIT Kharagpur. The development process includes engineering of the stimulation system, incorporation of safety and monitoring components, laboratory/bench validation, and preparation of units for clinical evaluation. The second phase involves implementation of the feasibility randomized controlled trial at participating clinical sites.
Before home use, participants allocated to the FES group will undergo structured training to establish safe and competent operation of the device. Training will include device orientation, electrode-placement instruction, safety procedures, supervised practice, and competency verification. The smartphone-based platform will support remote supervision and monitoring during the home-use period.
The feasibility study is intended primarily to establish whether the intervention can be delivered safely and practically in a home setting and whether participants can use the technology with limited direct clinical assistance. Information generated from recruitment, retention, adherence, safety, device usability, and preliminary functional outcomes will be used to refine the intervention and study procedures and to inform the design and sample-size planning of a subsequent fully powered randomized controlled trial.
The study also provides an opportunity to evaluate the integration of rehabilitation technology, remote clinical support, and home-based FES delivery within the Indian stroke rehabilitation setting. If feasibility criteria are met, the findings may support further evaluation and potential wider implementation of technology-enabled home rehabilitation for people with post-stroke disability.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Dr. Jeyaraj D Pandian, MD DM
- 电话号码:+91 9915784750
- 邮箱:jeyarajpandian@hotmail.com
研究联系人备份
- 姓名:Dr. Dimple Dawar, OT
- 电话号码:+91 9872354078; +1 905 9627200
- 邮箱:dawardimple682@gmail.com
学习地点
-
-
Punjab
-
Ludhiana、Punjab、印度、141008
- Christian Medical College and Hospital
-
接触:
- Dr Dimple Dawar
- 电话号码:9872354078
- 邮箱:dawardimple682@gmail.com
-
-
Tamil Nadu
-
Vellore、Tamil Nadu、印度、632004
- Christian Medical College and Hospital, Vellore
-
接触:
- Dr Angel Miraclin
- 电话号码:9488043281
- 邮箱:angel_miraclin@yahoo.com
-
-
West Bengal
-
Kharagpur、West Bengal、印度、721302
- Indian Institute of Technology, Kharagpur-IIT
-
接触:
- Prof Manjunatha Mahadevappa
- 电话号码:9475329788
- 邮箱:mmaha2emb@gmail.com
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Age ≥ 18 years with ischemic or hemorrhagic stroke (one month to one year post stroke)
- Clinical evidence of mild to moderate lower-limb weakness, defined as Manual Muscle Test (MMT) grade 2 or 3 in one or more target muscle groups (e.g., tibialis anterior, quadriceps, hamstrings) on the affected side.
- Cognitively able to follow instructions and provide informed consent (e.g., MMSE ≥ 24 or equivalent screening, or judged capable by the investigator).
- Access to a compatible smartphone and home internet service and willing/able to use the tele-rehab app.
- Skin at electrode application sites intact (no open wounds) and no dermatologic condition that would prevent safe application of the sleeve.
Exclusion Criteria:
- Implanted electronic medical device contraindicated with FES (e.g., pacemaker, implantable cardioverter-defibrillator) or other metallic implants near stimulation site that the treating clinician deems a contraindication.
- Active seizure disorder (epilepsy) that is uncontrolled or where stimulation could increase seizure risk, diabetes mellitus.
- Pregnancy or breastfeeding.
- Known allergy to materials used in the FES sleeve or electrodes.
- Severe spasticity in target muscle groups (e.g., Modified Ashworth Scale ≥ 3) that prevents functional stimulation or safe participation.
- Severe cardiovascular instability or uncontrolled medical conditions that make participation unsafe (e.g., unstable angina, recent myocardial infarction within 3 months, uncontrolled hypertension-systolic >180 mmHg or diastolic >110 mmHg at screening).
- Severe cognitive impairment, active psychiatric illness, or communication barriers that preclude safe device use or reliable consent/assessment.
- Open wounds, skin infection, severe dermatitis, or other skin conditions at electrode or sleeve contact sites.
- Participation in another interventional trial that would conflict with outcomes or safety reporting for this sub study.
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Home-Based FES
Participants will receive home-based FES for lower-limb rehabilitation for 12 weeks. |
FES will be applied to the quadriceps, tibialis anterior, and hamstrings for 30 minutes per session, 5 sessions per week, for 12 weeks, supported by a smartphone-based telerehabilitation platform for training, adherence monitoring, safety monitoring, and remote clinician support. |
|
有源比较器:Standard Rehabilitation
Participants will receive standard outpatient care and home-based rehabilitation without FES. |
Participants will receive standard outpatient care and home-based rehabilitation without FES, with equivalent remote clinician contact and education. |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
6-minute walk test (6MWT)
大体时间:Baseline 12 weeks
|
The primary outcome of this study is 6MWT, a validated measure of functional walking endurance and lower limb mobility in stroke survivors. Participants will be instructed to walk at their usual pace along a flat, unobstructed path for six minutes, with total distance covered recorded in meters. The 6 MWT will be conducted at baseline and at the end of the intervention period after 12 weeks. |
Baseline 12 weeks
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Recruitment rate
大体时间:Baseline to 12 weeks.
|
Recruitment will be assessed as the proportion of eligible participants who consent to participate in the study. The numbers approached, screened, eligible and enrolled will be recorded. Each site will aim to recruit an average of 1 or 2 participants per month. |
Baseline to 12 weeks.
|
|
Adherence rate
大体时间:Baseline to 12 weeks.
|
Adherence rate will be calculated as the number and proportion of prescribed sessions attended by each participant. We anticipate that 80 percent of participants will complete the total scheduled sessions. |
Baseline to 12 weeks.
|
|
Retention rate
大体时间:Baseline to 12 weeks.
|
Retention rate proportion of participants who complete the study through final assessment point to meet or exceed the minimal acceptable level of 85 percent across the full study duration. |
Baseline to 12 weeks.
|
|
Independent Use Ability
大体时间:Baseline to 12 weeks.
|
The feasibility of independent home-based FES use will be assessed by determining whether participants can safely and correctly don, operate, and remove the FES without direct clinician assistance. This will be monitored through observation during initial training sessions (video-supervised), self-reported ease of use using 5-point Likert scale, platform logs confirming successful device activation and completion of stimulation cycles and number of remote troubleshooting contacts required during the study. It will include total minutes of active FES use, average duration per session, and proportion of sessions in which the device was used as prescribed. An acceptable device usage rate will be defined as participants engaging in >75% of the expected device on-time across all scheduled sessions. |
Baseline to 12 weeks.
|
合作者和调查者
调查人员
- 首席研究员:Dr. Jeyaraj D Pandian, MD DM、Christian Medical College and Hospital, Ludhiana, India
出版物和有用的链接
一般刊物
- Popovic MR, Curt A, Keller T, Dietz V. Functional electrical stimulation for grasping and walking: indications and limitations. Spinal Cord. 2001 Aug;39(8):403-12. doi: 10.1038/sj.sc.3101191.
- Covarrubias-Escudero F, Balbontin-Miranda F, Urzua-Soler B, Ciuffardi R, Munoz M, Hernandez V, Appelgren-Gonzalez JP. Home-based functional electrical stimulation protocol for people with chronic stroke. Efficacy and usability of a single-center cohort. Artif Organs. 2025 Jul;49(7):1141-1152. doi: 10.1111/aor.14922. Epub 2024 Dec 12.
- Shendkar C, Lenka PK, Biswas A, Kumar R, Mahadevappa M. Design and development of a low-cost biphasic charge-balanced functional electric stimulator and its clinical validation. Healthc Technol Lett. 2015 Oct 21;2(5):129-34. doi: 10.1049/htl.2015.0001. eCollection 2015 Oct.
- Fang Y, Li J, Liu S, Wang Y, Li J, Yang D, Wang Q. Optimization of electrical stimulation for the treatment of lower limb dysfunction after stroke: A systematic review and Bayesian network meta-analysis of randomized controlled trials. PLoS One. 2023 May 11;18(5):e0285523. doi: 10.1371/journal.pone.0285523. eCollection 2023.
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- FES
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
Individual participant data will not be shared because the study protocol does not include a plan for sharing individual-level participant data. Study findings will be disseminated through scientific publications and presentations while protecting participant confidentiality and privacy.""Individual participant data will not be shared because the study protocol does not include a plan for sharing individual-level participant data. Study findings will be disseminated through scientific publications and presentations while protecting participant confidentiality and privacy.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.